Understanding Dapagliflozin (5mg) and Vildagliptin SR (50mg) in Diabetes Management

Managing type 2 diabetes requires effective, consistent treatment to maintain blood sugar levels and prevent complications. Dapagliflozin 5mg, Vildagliptin SR (50mg), branded as DAPA VILDA 50/5, is a dual-action oral medication designed to help patients achieve better glycemic control while supporting overall health.

Patients often search for dapagliflozin 5 mg, vildagliptin SR 50 mg, and want to understand how these medicines work together. This guide provides comprehensive insights on Dapagliflozin (5mg), Vildagliptin SR (50mg), including uses, dosage, precautions, side effects, and why Steris Healthcare is a reliable choice for diabetes management.

What is Dapagliflozin (5mg), Vildagliptin SR (50mg)?

Dapagliflozin (5mg), Vildagliptin SR (50mg) is a combination of two anti-diabetic agents:

• Dapagliflozin 5 mg: A Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor that helps remove excess glucose through urine, lowering blood sugar levels.

• Vildagliptin SR 50 mg: A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that increases insulin secretion in response to meals and reduces glucagon levels.

Together, Dapagliflozin (5mg), Vildagliptin SR 50mg offers a comprehensive approach to type 2 diabetes management.

Uses of Dapagliflozin (5mg), Vildagliptin SR (50mg)

Dapagliflozin (5mg), Vildagliptin SR (50mg) is prescribed for:

• Type 2 Diabetes Mellitus: Controls high blood sugar levels and improves HbA1c.

• Weight Management Support: Dapagliflozin may help in mild weight reduction due to glucose excretion.

• Cardiovascular Support: May provide additional heart and kidney protection in diabetic patients.

• Dual Mechanism Action: Combines glucose excretion and enhanced insulin secretion for better glycemic control.

By targeting blood sugar through complementary mechanisms, Dapagliflozin (5mg), Vildagliptin SR (50mg) ensures more stable blood glucose levels throughout the day.

How Dapagliflozin (5mg), Vildagliptin SR (50mg) Works

• Dapagliflozin 5 mg reduces glucose reabsorption in the kidneys, helping excess sugar leave the body via urine.

• Vildagliptin SR 50 mg stimulates insulin release and inhibits glucagon production, especially after meals.

• Together, this combination reduces both fasting and postprandial blood sugar effectively.

This makes DAPA VILDA 50/5 a highly effective option for patients struggling with type 2 diabetes management.

Dosage and Administration

• Typical Adult Dose: One tablet daily or as prescribed by your doctor

• Can be taken with or without food, but preferably at the same time each day

• Drink plenty of water to prevent dehydration, as Dapagliflozin increases urine output

• Regular monitoring of blood sugar, kidney function, and liver function is recommended

Possible Side Effects

Most patients tolerate Dapagliflozin (5mg), Vildagliptin SR (50mg) well. Common side effects may include:

• Mild urinary tract infections (UTIs)

• Increased urination

• Headache or dizziness

• Nausea or mild stomach discomfort

• Rare: Low blood sugar (hypoglycemia) when used with other anti-diabetic drugs

Consult your healthcare provider if you notice persistent or severe side effects.

Precautions

• Inform your doctor if you have kidney disease, liver problems, or a history of UTIs

• Drink sufficient water to prevent dehydration

• Pregnant or breastfeeding women should seek medical advice before use

• Avoid skipping doses to maintain consistent blood sugar control

• Regular blood tests are advised to monitor kidney and liver health

Why Choose Steris Healthcare for DAPA VILDA 50/5

Steris Healthcare is a leading pharmaceutical company committed to:

• WHO-GMP certified manufacturing standards

• Providing safe, effective, and affordable medications

• Nationwide availability across India

• Patient-focused approach ensuring trust and reliability

DAPA VILDA 50/5 (Dapagliflozin (5mg), Vildagliptin SR (50mg)) combines quality, efficacy, and convenience, making it a preferred choice for type 2 diabetes management.

Frequently Asked Questions

Q1: How to take Dapagliflozin (5mg), Vildagliptin SR (50mg)?
Take one tablet daily at the same time, with or without food, as advised by your doctor.

Q2: Can DAPA VILDA 50/5 cause low blood sugar?
It rarely causes hypoglycemia when used alone but may increase the risk if taken with other anti-diabetic drugs.

Q3: Is it safe for patients with kidney issues?
Consult your doctor. Dapagliflozin may require dose adjustment based on kidney function.

Q4: Can I drink water while taking this medicine?
Yes, adequate hydration is important as Dapagliflozin increases urine output.

Q5: Can it be used long-term?
Yes, under regular medical supervision with periodic monitoring of blood sugar, kidney, and liver function.

Patient Perspective

For patients managing type 2 diabetes, DAPA VILDA 50/5 provides reliable and convenient blood sugar control. By combining dapagliflozin 5 mg and vildagliptin SR 50 mg, it stabilizes glucose levels, supports weight management, and reduces the risk of long-term complications, allowing patients to maintain a healthier and more active lifestyle.

Conclusion

Dapagliflozin (5mg), Vildagliptin SR (50mg) is a safe, effective, and convenient solution for type 2 diabetes management. With Steris Healthcare’s commitment to quality, patients can rely on this medicine for consistent blood sugar control and overall health support.

Take control of your diabetes today. Consult your doctor about DAPA VILDA 50/5 and experience trusted care from Steris Healthcare.